Croatia vs Portugal: Life science patents granted, by technology
Croatia
1 patents
in 2023
Portugal
2 patents
in 2023
Croatia rank
55th
Portugal rank
52nd
Life science patents granted, by technology over time
- Croatia
- Portugal
How they compare
Portugal currently reports 2 patents against 1 patents in Croatia, a difference of 1 patents.
That makes Portugal's figure about 2.0 times Croatia's.
The two have swapped places 4 times across 27 shared years of data; in 1995 it was Portugal ahead.
Croatia ranks 55th and Portugal ranks 52nd of 65 countries.
Across the 4 decades both report, Croatia averaged higher in 2 and Portugal in 2.
Head to head by decade
| Decade | Croatia | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 27.8 patents | 206.8 patents | 179 patents | Portugal |
| 2000s | 44.44 patents | 8.56 patents | 35.89 patents | Croatia |
| 2010s | 33 patents | 4.67 patents | 28.33 patents | Croatia |
| 2020s | 3.5 patents | 5.5 patents | 2 patents | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Croatia or Portugal?
- Portugal, at 2 patents against 1 patents in Croatia as of 2023.
- What is the difference in life science patents granted, by technology between Croatia and Portugal?
- 1 patents, with Portugal ahead.
- How many years of comparable data are there for Croatia and Portugal?
- 27 years are reported by both, from 1995 to 2023.
- How do Croatia and Portugal rank globally for life science patents granted, by technology?
- Croatia ranks 55th and Portugal ranks 52nd of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.